GFPT2 unveiled as a biomarker for mesothelioma diagnosis and prognosis
Oct. 14, 2024
Researchers from Nanjing First Hospital reported that glutamine-fructose-6-phosphate transaminase 2 (GFPT2) may be considered a diagnostic and prognostic marker of mesothelioma.